FULCRUM THERAPEUTICS, INC. (FULC) Shareholders’ equity 2020–2025
FULCRUM THERAPEUTICS, INC. (FULC) shareholders’ equity at each fiscal year-end, per SEC filings.
$349.0MFY2025 · since FY2020: $95.2M → $349.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $349.0M | +43.6% |
| FY2024 | $243.0M | +3.3% |
| FY2023 | $235.2M | +18.2% |
| FY2022 | $198.9M | -6.0% |
| FY2021 | $211.5M | +122.2% |
| FY2020 | $95.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice